Align Technology (ALGN) The 44th Annual William Blair Growth Stock Conference summary
Event summary combining transcript, slides, and related documents.
The 44th Annual William Blair Growth Stock Conference summary
31 Jan, 2026Company History and Strategic Direction
27 years of innovation in dental aligners, evolving from a startup to a global leader in 3D printing and digital orthodontics, with over 17.6 million Invisalign patients treated globally and a network of 261,000 trained doctors.
Focused on a patient-centric, direct-to-doctor model, emphasizing clinical efficacy, safety, and accessibility for all ages.
Maintains a dedicated sales and clinical education force of 5,000 and 22,000 employees as of March 2024.
Strategic growth drivers include international expansion, patient demand, orthodontic conversion, and GP engagement.
Avoids unrelated acquisitions, focusing exclusively on orthodontic and dental solutions.
Product and Technology Innovation
Launched iTero Lumina scanner, Multi-Direct Capture technology, and Invisalign Smile Architect platform, with iTero scanners surpassing 100,000 units sold and the new Lumina model offering a 3x wider field of capture.
Developed proprietary plastics, SmartTrack, and SmartForce technologies, enabling treatment of 100% of orthodontic cases and optimizing aligner performance.
AI and machine learning have powered treatment planning and product development for over a decade, enabling personalized, efficient care.
3D printing advancements enable direct fabrication of devices, reducing material waste by 90% and allowing for custom material placement.
Invisalign Palatal Expander System offers up to 9mm expansion, available in the US, Canada, Australia, and New Zealand, with phased global rollout pending regulatory approvals.
Financial Performance and Market Trends
Q1 2024 total revenues reached $997.4M, up 5.8% year-over-year, with clear aligner revenues at $817.3M and systems/services at $180.2M.
Clear aligner case volume grew 2.4% year-over-year, with international shipments up 5.3% year-over-year.
Non-case clear aligner revenues, including Vivera retainers and subscription programs, rose 7.5% year-over-year.
Systems and services revenues increased 17.5% year-over-year, with intraoral digital scans for Invisalign case submission at 95.6% in the Americas.
Full-year revenue guidance raised to 7% growth at the midpoint, reflecting stable market conditions and product momentum.
Latest events from Align Technology
- Voting standard for Proposal 4 clarified; majority approval of shares present or represented required.ALGN
Proxy filing17 Apr 2026 - Record Q4 and FY2025 revenues, strong Clear Aligner and DSO growth, and positive 2026 outlook.ALGN
Q4 202517 Apr 2026 - Record revenues, robust governance, and enhanced shareholder rights highlight this year's proxy.ALGN
Proxy filing7 Apr 2026 - Virtual Annual Meeting to address director elections, compensation, auditor, and bylaw proposals.ALGN
Proxy filing7 Apr 2026 - Record revenues, robust governance, and enhanced shareholder rights highlight this year's proxy.ALGN
Proxy filing27 Mar 2026 - Broad-based growth, strong DSO performance, and stable outlook drive confidence for 2026.ALGN
Barclays 28th Annual Global Healthcare Conference11 Mar 2026 - Strong growth in Europe and APAC, with product innovation and efficiency boosting margins.ALGN
Leerink Global Healthcare Conference 202610 Mar 2026 - Digital dentistry expansion, AI-driven innovation, and global growth drive strong financial outlook.ALGN
Investor Day 20253 Feb 2026 - Q2 2024 revenue up 2.6% to $1.03B; margin pressured by FX, mix, and legal settlement.ALGN
Q2 20243 Feb 2026